| Eli Lilly targets FDA approval for weight loss medication () |
| New COVID-19 variant with high transmissibility identified () |
| CMS to punish hospitals sooner for price transparency noncompliance () |
| Walmart Health expands to Oklahoma () |
| Kaiser Permanente acquiring Geisinger, launching new nonprofit () |
| Movers & Shakers: Kaiser Permanente, Corewell Health, Allina Health name new leadership () |
| Conifer, Welldoc partner in digital health app () |
| Global healthcare partnership targets ‘the big catch-up’ vaccination initiative () |
| Florida surgeon general altered COVID-19 study findings () |
| Health editors quit in protest over high publishing charges () |
| Supreme Court upholds full access to abortion pill () |
| Seema Verma, former CMS head, joins Oracle () |
| Infusion system recalled for possible leaks after multiple complaints () |
| OTC Narcan will cost less than $50 () |
| Judge halts all lawsuits related to J&J talc formula () |
| DOJ targets COVID-related healthcare fraud () |
| GE Healthcare solution, billed as a 'unified approach to patient monitoring,' gains FDA clearance () |
| Supreme Court delays final decision on abortion pill for 2 more days () |
| CVS Health names former Humana exec the new president of Aetna () |
| FDA announces shift to simplify COVID-19 vaccines () |
| Hospital CEO exits on the rise again () |
| Phillips partners with Amazon to host EI offering, advance AI tools () |
| Poverty is a leading cause of death () |
| Merck to acquire Prometheus Biosciences for $10.8B () |
| Cano Health separates leadership roles following board member exits () |
| Moderna, Merck say new combination treatment boosts skin cancer survival () |
| Supreme Court halts restrictions on abortion pill () |
| Outcome Health execs convicted in $1B fraud scheme () |
| DOJ to appeal abortion pill case to Supreme Court () |
| Movers & Shakers: CEO changes at Johns Hopkins/UMMS, Central Health () |
| Political climate leads to loss of labor and delivery services () |
| Sanofi’s $2.9B acquisition of Provention Bio delayed by FTC review () |
| Sexually transmitted infections are on the rise, warns CDC () |
| CMS proposes 2.8% rate increase for inpatient payments in 2024 () |
| Drugmakers condemn judge’s suspension of abortion pill access () |
| Best and worst states for children’s healthcare () |
| Private equity in healthcare: Deals decreased in 2022, but market was still active () |
| Healthcare leaders make list of world's richest people () |
| Abortion pill legality in question after conflicting federal judgments () |
| Serious patient safety events up 19% in 2022 () |
| Medtronic, DaVita launch new kidney health company () |
| Industry groups applaud bill connecting Medicare payments to inflation () |
| These health systems have the biggest digital health portfolios () |
| Cano Health leadership team in disarray after directors resign () |
| $300M research fund will focus on Alzheimer’s () |
| Johnson & Johnson offers nearly $9B to settle talc lawsuits () |
| Liver specialists among first to be ably aided by ChatGPT () |
| Too much too soon? Elon Musk, other tech leaders pause AI development to review ethics () |
| The healthiest and unhealthiest US cities () |
| Illumina ordered to divest Grail () |
| CMS finalizes 2024 MA payment rule with rate bump () |
| FDA turns up sterility issues at eye drop facility linked to deaths, vision loss () |
